Chemical Component Summary

NameAMINOGUANIDINE
Identifiers1-aminoguanidine
FormulaC H6 N4
Molecular Weight74.08
TypeNON-POLYMER
Isomeric SMILESC(=N)(N)NN
InChIInChI=1S/CH6N4/c2-1(3)5-4/h4H2,(H4,2,3,5)
InChIKeyHAMNKKUPIHEESI-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count11
Chiral Atom Count0
Bond Count10
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB05383 
NamePimagedine
Groupsinvestigational
DescriptionPimagedine has been developed by Synvista Therapeutics, Inc for the treatment of diabetic kidney disease. It is an advanced glycation end product inhibitor which manages diabetic nephropathy, either alone or in combination with other therapies. It is beneficial in treating patients with diabetic nephropathy.
Synonyms
  • Pimagedine hydrochloride
  • Aminoguanidine
  • Pimagedine
  • Guanyl hydrazine
  • Aminate base
IndicationInvestigated for use/treatment in diabetic kidney disease.
Categories
  • Amidines
  • Enzyme Inhibitors
  • Nitric Oxide Synthase, antagonists & inhibitors
  • OCT2 Inhibitors
CAS number79-17-4

Drug Targets

NameTarget SequencePharmacological ActionActions
Nitric oxide synthase, inducibleMACPWKFLFKTKFHQYAMNGEKDINNNVEKAPCATSSPVTQDDLQYHNLS...unknowninhibitor
Aldose reductaseMASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQ...unknown
Metalloproteinase inhibitor 3MTPWLGLIVLLGSWSLGDWGAEACTCSPSHPQDAFCNSDIVIRAKVVGKK...unknown
Solute carrier family 22 member 2MPTTVDDVLEHGGEFHFFQKQMFFLLALLSATFAPIYVGIVFLGFTPDHR...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDRAGNEU
PubChem2146
ChEBICHEBI:40618
ChEMBLCHEMBL225304
PharosCHEMBL225304